To apply for the Amanta Healthcare IPO, investors can use their trading or demat account through their broker’s online platform. After logging in, navigate to the IPO section and select the Amanta Healthcare IPO from the active listings. Enter the number of lots to apply for, ensuring it meets the minimum lot size requirement, and choose a bid price within the specified price band. Provide your UPI ID for payment authorization, confirm that sufficient funds are available, and review all application details carefully. Submit the application and approve the UPI mandate before the cut-off time on the last day of the IPO subscription period to complete the process.
For complete details on this public offering, visit the Amanta Healthcare IPO page on our website.
Amanta Healthcare IPO Application Process
The Amanta Healthcare IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:
Step 1: Login to Your Trading Platform
Access your trading account using the broker's app or website.
Step 2: Navigate to the IPO Section
Go to the IPO section to view active IPO listings.
Step 3: Select the Open IPO and Click Apply
Locate Amanta Healthcare IPO in the list of available IPOs and click the ‘Apply’ button.
Step 4: Enter the Quantity of Shares You Wish to Apply For
Specify the number of shares (minimum lot size: 119 shares) within the price band of ₹120 to ₹126 per share.
Step 5: Provide Your UPI ID
Enter your UPI ID for payment authorization and ensure sufficient funds in your bank account.
Step 6: Confirm the Application
Review your application details and confirm the UPI mandate before 5 PM on the last application day.
Step 7: Complete the Process and Wait for Allotment
Submit the application and monitor the allotment status to check if shares have been allocated to you.
Additional Read: Amanta Healthcare IPO Investment Guide: Objectives & Opportunities
About Amanta Healthcare IPO: Overview and Key Facts
Amanta Healthcare Limited, incorporated in December 1994, is a pharmaceutical company engaged in the development, manufacturing, and marketing of sterile liquid products, primarily parenterals. The company also manufactures medical devices, including irrigation solutions, first-aid products, and eye lubricants. Its products cover therapeutic areas such as fluid therapy, ophthalmic care, respiratory care, and diluents, and are packaged using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. The company operates both large-volume and small-volume parenterals, with container volumes ranging from 2ml to 1000ml.
The company markets its products through national and international sales channels, as well as partnerships with Indian and foreign pharmaceutical firms. In India, over 45 generic products are distributed through a network of 320 distributors and stockists. Internationally, the company exports branded products to countries including Africa, Latin America, and the UK, with products registered in multiple regulatory jurisdictions.
The Amanta Healthcare IPO is scheduled to open on September 1, 2025, and close on September 3, 2025. The issue size is 1,00,00,000 shares, aggregating up to ₹126 crore, with a price band of ₹120 to ₹126 per share. The IPO aims to fund capital expenditure for new manufacturing lines and general corporate purposes. Applications require a minimum lot of 119 shares, and the tentative allotment date is September 4, 2025.
To check your application status, visit the Amanta Healthcare IPO Allotment Status page on Bajaj Broking’s website.